Investors seeking to outperform the market often focus on hand-picking stocks. Selecting the right ones has proven to be a key factor in boosting wealth.
The closing price of Bruker Corp (NASDAQ: BRKR) was $48.44 for the day, up 0.90% from the previous closing price of $48.01. In other words, the price has increased by $0.90 from its previous closing price. On the day, 1.31 million shares were traded. BRKR stock price reached its highest trading level at $48.7173 during the session, while it also had its lowest trading level at $47.8.
Ratios:
Our analysis of BRKR’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 0.91 and its Current Ratio is at 1.85. In the meantime, Its Debt-to-Equity ratio is 0.83 whereas as Long-Term Debt/Eq ratio is at 0.82.
On December 09, 2025, Goldman started tracking the stock assigning a Sell rating and target price of $40.
On November 20, 2025, Rothschild & Co Redburn started tracking the stock assigning a Buy rating and target price of $60.Rothschild & Co Redburn initiated its Buy rating on November 20, 2025, with a $60 target price.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Dec 01 ’25 when PACKER RICHARD A sold 5,028 shares for $48.38 per share. The transaction valued at 243,230 led to the insider holds 89,174 shares of the business.
RICHARD A PACKER bought 5,028 shares of BRKR for $243,230 on Dec 01 ’25. On Nov 06 ’25, another insider, ORNELL JOHN A, who serves as the Director of the company, sold 6,233 shares for $39.00 each. As a result, the insider received 243,087 and left with 35,212 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, BRKR now has a Market Capitalization of 7360029184 and an Enterprise Value of 9174929408. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 45.24. For the stock, the TTM Price-to-Sale (P/S) ratio is 2.14 while its Price-to-Book (P/B) ratio in mrq is 3.02. Its current Enterprise Value per Revenue stands at 2.668 whereas that against EBITDA is 15.684.
Stock Price History:
The Beta on a monthly basis for BRKR is 1.17, which has changed by -0.18099624 over the last 52 weeks, in comparison to a change of 0.17823458 over the same period for the S&P500. Over the past 52 weeks, BRKR has reached a high of $64.64, while it has fallen to a 52-week low of $28.53. The 50-Day Moving Average of the stock is 11.14%, while the 200-Day Moving Average is calculated to be 23.90%.
Shares Statistics:
BRKR traded an average of 2.74M shares per day over the past three months and 1697660 shares per day over the past ten days. A total of 151.39M shares are outstanding, with a floating share count of 103.19M. Insiders hold about 32.08% of the company’s shares, while institutions hold 89.00% stake in the company. Shares short for BRKR as of 1765756800 were 11497888 with a Short Ratio of 4.19, compared to 1763078400 on 13424506. Therefore, it implies a Short% of Shares Outstanding of 11497888 and a Short% of Float of 16.290002.
Dividends & Splits
With its trailing 12-month dividend rate of 0.2, BRKR has a forward annual dividend rate of 0.20. Against a Trailing Annual Dividend Yield of 0.004165799. The stock’s 5-year Average Dividend Yield is 0.31.
Earnings Estimates
Current recommendations for the stock of the company come from 13.0 analysts. The consensus estimate for the next quarter is $0.42, with high estimates of $0.61 and low estimates of $0.27.
Analysts are recommending an EPS of between $1.9 and $1.86 for the fiscal current year, implying an average EPS of $1.88. EPS for the following year is $2.15, with 15.0 analysts recommending between $2.44 and $2.0.
Revenue Estimates
It is expected that $90B in revenue will be generated in. The current quarter, according to 12 analysts. It ranges from a high estimate of $966.5M to a low estimate of $952.51M. As of. The current estimate, Bruker Corp’s year-ago sales were $979.6MFor the next quarter, 12 analysts are estimating revenue of $803.82M. There is a high estimate of $828.43M for the next quarter, whereas the lowest estimate is $770M.
A total of 13 analysts have provided revenue estimates for BRKR’s current fiscal year. The highest revenue estimate was $3.43B, while the lowest revenue estimate was $3.41B, resulting in an average revenue estimate of $3.42B. In the same quarter a year ago, actual revenue was $3.37BBased on 13 analysts’ estimates, the company’s revenue will be $3.47B in the next fiscal year. The high estimate is $3.55B and the low estimate is $3.43B.
